Cytokine profile during high-dose rhG-CSF therapy in severe congenital neutropenia
- 1 January 1994
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 45 (1) , 58-62
- https://doi.org/10.1002/ajh.2830450109
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Recombinant human stem cell factor, a c‐kit ligand, stimulates granulopoiesis in severe congenital neutropeniaAmerican Journal of Hematology, 1993
- Detection of soluble IL‐2 receptor in the serum of patients with myelodysplastic syndromes: induction under therapy with GM‐CSFBritish Journal of Haematology, 1991
- Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropeniaBlood, 1991
- Soluble interleukin-2 receptors in patients with nasopharyngeal carcinomaCancer, 1991
- Blood mononuclear cells from patients with severe congenital neutropenia are capable of producing granulocyte colony-stimulating factorBlood, 1991
- Animal models for the biological effects of continuous high cytokine levelsAnnals of Hematology, 1990
- THE CONSEQUENCES OF EXCESS LEVELS OF HAEMOPOIETIC GROWTH FACTORSBritish Journal of Haematology, 1990
- Effects of Recombinant Human Granulocyte Colony-Stimulating Factor on Neutropenia in Patients with Congenital AgranulocytosisNew England Journal of Medicine, 1989
- INFANTILE GENETIC AGRANULOCYTOSISActa Paediatrica, 1975
- Infantile Genetic Agranulocytosis (Agranulocytosis infantilis hereditaria) A New Recessive Lethal Disease in ManActa Paediatrica, 1956